Pulmonx (LUNG)
(Delayed Data from NSDQ)
$8.36 USD
+0.44 (5.56%)
Updated Jul 22, 2024 04:00 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for Pulmonx Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 69 | 54 | 48 | 33 | 33 |
Cost Of Goods | 18 | 14 | 13 | 12 | 10 |
Gross Profit | 51 | 40 | 36 | 21 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 113 | 99 | 83 | 54 | 40 |
Income After Depreciation & Amortization | -62 | -59 | -47 | -32 | -18 |
Non-Operating Income | 5 | 1 | 0 | 4 | 0 |
Interest Expense | 3 | 1 | 1 | 3 | 2 |
Pretax Income | -60 | -59 | -48 | -32 | -20 |
Income Taxes | 1 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -61 | -59 | -49 | -32 | -21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -61 | -59 | -49 | -32 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -61 | -57 | -46 | -31 | -18 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 0 |
Income After Depreciation & Amortization | -62 | -59 | -47 | -32 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 37.98 | 37.10 | 36.13 | 10.19 | NA |
Diluted EPS Before Non-Recurring Items | -1.60 | -1.59 | -1.35 | -3.16 | NA |
Diluted Net EPS (GAAP) | -1.60 | -1.59 | -1.35 | -3.16 | -11.66 |
Fiscal Year end for Pulmonx Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 18.85 | 19.28 | 17.67 | 17.19 |
Cost Of Goods | NA | 4.78 | 4.88 | 4.64 | 4.46 |
Gross Profit | NA | 14.08 | 14.40 | 13.03 | 12.73 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 28.61 | 28.32 | 28.21 | 29.17 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -14.53 | -13.92 | -15.18 | -16.44 |
Non-Operating Income | NA | 1.86 | 1.18 | 1.23 | 1.25 |
Interest Expense | NA | 0.88 | 0.90 | 0.89 | 0.86 |
Pretax Income | NA | -13.56 | -13.64 | -14.84 | -16.06 |
Income Taxes | NA | 0.19 | 0.25 | 0.06 | 0.14 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -13.75 | -13.89 | -14.90 | -16.20 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -13.75 | -13.89 | -14.90 | -16.20 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 38.64 | 38.38 | 38.12 | 37.82 |
Diluted EPS Before Non-Recurring Items | NA | -0.36 | -0.36 | -0.39 | -0.43 |
Diluted Net EPS (GAAP) | NA | -0.36 | -0.36 | -0.39 | -0.43 |